Full Text View
Tabular View
No Study Results Posted
Related Studies
Study to Determine the Safety and Tolerability of Sotatercept (ACE-011) in Adults With Beta( β)- Thalassemia.
This study is currently recruiting participants.
Verified May 2013 by Celgene Corporation
Study NCT01571635   Information provided by Celgene Corporation

First Received on April 3, 2012.   Last Updated on May 16, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Beta Thalassemia Major
Beta Thalassemia Intermedia
Additional conditions recognized in this trial
Beta-Thalassemia
Thalassemia
More general conditions related to this trial
Anemia
Anemia, Hemolytic
Anemia, Hemolytic, Congenital
Genetic Diseases, Inborn
Hematologic Diseases
Hemoglobinopathies
Interventions listed in this trial
SOTATERCEPT (ACE-011)
Sponsors listed in this trial
Celgene Corporation


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services